←Back to structures
SR-VP_0-2_scaffold_141_4556078_prodigal-single.1__X__X__00055
Bact-VirSR-VP_0-2_scaffold_141_4556078_prodigal-single.1__X__X__00055
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 2-116
Domain cluster:
rep: JQ362498.1__AFF28142.1__PAU_144__00137__D92-206
CATH (9)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 1wfxA02 | 3.20.170.30 | Alpha Beta › Alpha-Beta Barrel › ADP-ribosylation fold › | 0.80 | 61.0 | 6.85e-01 | 97.4% | 100.0% |
| 4gv2A02 | 3.90.228.10 | Alpha Beta › Alpha-Beta Complex › Phosphoenolpyruvate Carboxykinase; domain 3 › | 0.78 | 69.0 | 5.53e-01 | 93.9% | 72.4% |
| 1gs0A02 | 3.90.228.10 | Alpha Beta › Alpha-Beta Complex › Phosphoenolpyruvate Carboxykinase; domain 3 › | 0.76 | 68.0 | 5.44e-01 | 95.7% | 71.6% |
| 7kw8A02 | 3.20.170.30 | Alpha Beta › Alpha-Beta Barrel › ADP-ribosylation fold › | 0.75 | 51.0 | 5.93e-01 | 87.0% | 100.0% |
| 3hkvA00 | 3.90.228.10 | Alpha Beta › Alpha-Beta Complex › Phosphoenolpyruvate Carboxykinase; domain 3 › | 0.73 | 66.0 | 5.47e-01 | 95.7% | 64.6% |
| 2x5yA00 | 3.90.228.10 | Alpha Beta › Alpha-Beta Complex › Phosphoenolpyruvate Carboxykinase; domain 3 › | 0.72 | 65.0 | 5.62e-01 | 95.7% | 66.1% |
| 3b82B00 | 3.90.175.10 | Alpha Beta › Alpha-Beta Complex › Diphtheria Toxin; domain 1 › Diphtheria Toxin, domain 1 | 0.71 | 66.0 | 5.34e-01 | 100.0% | 74.9% |
| 6tl1B01 | 3.90.228.10 | Alpha Beta › Alpha-Beta Complex › Phosphoenolpyruvate Carboxykinase; domain 3 › | 0.71 | 64.0 | 5.25e-01 | 96.5% | 65.8% |
| 2o0pA00 | 3.20.170.20 | Alpha Beta › Alpha-Beta Barrel › ADP-ribosylation fold › Protein of unknown function DUF952 | 0.65 | 57.0 | 5.80e-01 | 98.3% | 96.5% |
ECOD (39)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 4296568 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.83 | 62.0 | 6.84e-01 | 96.5% | 92.6% |
| 4546240 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.82 | 59.0 | 6.62e-01 | 98.3% | 94.4% |
| 4303698 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.82 | 59.0 | 6.47e-01 | 99.1% | 90.4% |
| 4008473 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.81 | 57.0 | 6.18e-01 | 89.6% | 83.8% |
| 4125268 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.81 | 59.0 | 6.60e-01 | 90.4% | 94.4% |
| 4622968 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.81 | 57.0 | 6.46e-01 | 90.4% | 92.2% |
| 5077692 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.81 | 63.0 | 6.59e-01 | 93.9% | 87.6% |
| 3905755 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.81 | 72.0 | 6.87e-01 | 93.0% | 96.9% |
| 3106804 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.81 | 61.0 | 6.50e-01 | 94.8% | 87.4% |
| 3256269 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.81 | 69.0 | 7.18e-01 | 95.7% | 97.1% |
| 4679144 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.81 | 58.0 | 6.42e-01 | 92.2% | 90.5% |
| 3908660 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.80 | 73.0 | 6.60e-01 | 95.7% | 80.7% |
| 5060086 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.79 | 58.0 | 6.32e-01 | 92.2% | 91.6% |
| 3262622 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.78 | 70.0 | 5.42e-01 | 95.7% | 71.7% |
| 4994805 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.78 | 61.0 | 6.45e-01 | 98.3% | 91.3% |
| 3258251 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.76 | 69.0 | 5.38e-01 | 95.7% | 66.2% |
| 3727394 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.76 | 69.0 | 5.20e-01 | 95.7% | 65.6% |
| 3242389 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.76 | 68.0 | 5.14e-01 | 95.7% | 60.0% |
| 3196342 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.76 | 64.0 | 5.44e-01 | 93.9% | 58.0% |
| 3602129 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.76 | 69.0 | 6.08e-01 | 97.4% | 88.3% |
| 3270835 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.76 | 68.0 | 5.35e-01 | 95.7% | 70.5% |
| 3252897 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.76 | 68.0 | 5.47e-01 | 95.7% | 69.0% |
| 4014210 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.75 | 68.0 | 5.30e-01 | 95.7% | 70.2% |
| 3798872 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.75 | 67.0 | 5.26e-01 | 95.7% | 66.1% |
| 3694624 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.75 | 68.0 | 5.13e-01 | 96.5% | 64.0% |
| 3724972 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.75 | 63.0 | 4.70e-01 | 92.2% | 38.5% |
| 3555152 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.74 | 67.0 | 5.63e-01 | 95.7% | 68.1% |
| 3922705 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.74 | 67.0 | 5.38e-01 | 95.7% | 61.0% |
| 4876939 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.72 | 66.0 | 5.52e-01 | 95.7% | 64.3% |
| 3241341 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.72 | 65.0 | 5.33e-01 | 96.5% | 71.9% |
| 3324343 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.72 | 65.0 | 5.36e-01 | 95.7% | 63.7% |
| 3562744 | 237.1.1.18 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › DUF3715 | 0.72 | 65.0 | 5.12e-01 | 95.7% | 67.3% |
| 3879371 | 237.1.1.1 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PARP | 0.71 | 64.0 | 5.39e-01 | 94.8% | 65.6% |
| 3410782 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.68 | 57.0 | 5.01e-01 | 96.5% | 62.5% |
| 3059252 | 237.1.1.11 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › RES | 0.67 | 60.0 | 5.38e-01 | 97.4% | 95.5% |
| 4937896 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.66 | 52.0 | 5.55e-01 | 93.9% | 96.0% |
| 3281812 | 237.1.1.29 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › DUF4291 | 0.63 | 56.0 | 4.77e-01 | 98.3% | 85.3% |
| 3597511 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.63 | 57.0 | 4.70e-01 | 96.5% | 68.7% |
| 3183175 | 237.1.1.4 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › PTS_2-RNA | 0.61 | 57.0 | 5.05e-01 | 100.0% | 84.4% |